



| Catalog No. | HW741016 |
|---|---|
| Description |
Samalizumab (HW741016) is a research-grade recombinant antibody targeting CD200. Produced in mammalian cells with native-like glycosylation.
Highlights
|
| Species reactivity | Human |
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Host species | Humanized |
| Isotype | IgG2-G4-kappa |
| Expression system | Mammalian Cells |
| Clonality | Monoclonal |
| Target | OX-2 membrane glycoprotein, MOX2, MOX1, CD200 |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G purified from cell culture supernatant. |
| Accession | P41217 |
| Form | Liquid |
| Storage buffer | 0.01M PBS, pH 7.4. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Alternate Names | ALXN6000, Anti-CD200, hB7V3V2G2G4, 1073059-33-2 |
| Background | OX-2 membrane glycoprotein (CD200) is a ~31 kDa protein. Costimulates T-cell proliferation. May regulate myeloid cell activity in a variety of tissues. |
| Note | For research use only. Not suitable for clinical or therapeutic use. |

Detects CD200 in indirect ELISAs.

SDS-PAGE for Research Grade Samalizumab.




Contact us for custom quotes, bulk requests and any other issues.
Mail: support@abinScience.com




+86-27-65523339
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский